At Sollis, we’re developing an investigational therapy to treat patients for whom conservative sciatica pain treatments have been ineffective.
Our Clonidine Micropellet (clonidine hydrochloride extended-release epidural micropellet) investigational treatment is designed to target the source of sciatica pain over time, while also reducing inflammation at the injured nerve.* Our goal is to develop rapid, durable pain relief that allows healing—using a non-opioid, non-steroid medication.
Learn more about clinical trials and review results and publications.
We are currently in the planning stages for upcoming trials. Check back soon for up-to-date information.
* The Sollis Clonidine Micropellet therapy is an investigational treatment for sciatica and has not been approved for use by the FDA.